Previous Section
Clinical Trials
1. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
- Author
- Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM;
- Institution
- Department of Medicine, Veterans Affairs Puget Sound Health Care System (VAPSHCS), and University of Washington School of Medicine, Seattle, WA 98108, USA. rbmontgo@u.washington.edu
- Journal
- Cancer. 2007 Sep 1;110(5):996-1002.
- Abstract URL
- Click here to view abstract
2. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
- Author
- Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA Jr;
- Institution
- Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. thompsoni@uthscsa.edu
- Journal
- J Clin Oncol. 2007 Jul 20;25(21):3076-81.
- Abstract URL
- Click here to view abstract
3. Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy.
- Author
- Romero S; Stanton G; DeFelice J; Schreiber F; Rago R; Fishman M;
- Institution
- Florida Cancer Specialists, Ft. Myers, FL, 33901-8108, USA.
- Journal
- Urol Oncol. 2007 Jul-Aug;25(4):284-90.
- Abstract URL
- Click here to view abstract
4. Attitudes of prostate cancer patients towards the diagnosis and treatment of their disease: findings from a multinational survey.
- Author
- Hardy C; Penn S; Morris T;
- Institution
- Fast Forward Research Ltd, Wilmslow, Cheshire, UK. claire.hardy@fastforwardresearch.com
- Journal
- Curr Med Res Opin. 2007 Sep;23(9):2107-16.
- Abstract URL
- Click here to view abstract
5. The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.
- Author
- van Adelsberg J; Gann P; Ko AT; Damber JE; Logothetis C; Marberger M; Schmitz-Drager BJ; Tubaro A; Harms CJ; Roehrborn C;
- Institution
- Merck Research Laboratories, Rahway, NJ 07065, USA. janet_vanadelsberg@merck.com
- Journal
- Curr Med Res Opin. 2007 Sep;23(9):2063-70.
- Abstract URL
- Click here to view abstract
6. A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.
- Author
- Gross M; Higano C; Pantuck A; Castellanos O; Green E; Nguyen K; Agus DB;
- Institution
- Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. mitchell.gross@cshs.org
- Journal
- BMC Cancer. 2007 Jul 27;7:142.
- Abstract URL
- Click here to view abstract
7. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
- Author
- Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML;
- Institution
- Department of Urology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA.
- Journal
- Urology. 2007 Jul;70(1):80-5.
- Abstract URL
- Click here to view abstract
8. An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer.
- Author
- Salzberg M; Rochlitz C; Morant R; Thalmann G; Pedrazzini A; Roggero E; Schonenberger A; Knuth A; Borner M;
- Institution
- University Hospital Basel, Switzerland.
- Journal
- Onkologie. 2007 Jul;30(7):355-60. Epub 2007 Jun 27.
- Abstract URL
- Click here to view abstract
9. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
- Author
- Kibel AS; Rosenbaum E; Kattan MW; Picus J; Dreicer R; Klein EA; Chatta GS; Nelson JB; DiPaola RS; Roth BJ; Cookson MS; Wilding G; Jarrard DF; Beer TM; Ryan CW; Petrylak DP; Benson MC; Partin AW; Garrett-Mayer E; Eisenberger MA;
- Institution
- Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63105, USA. kibela@wustl.edu
- Journal
- J Urol. 2007 May;177(5):1777-81.
- Abstract URL
- Click here to view abstract
10. Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis.
- Author
- Ates M; Teber D; Gozen AS; Tefekli A; Sugiono M; Hruza M; Rassweiler J;
- Institution
- Department of Urology, SLK-Klinikum Heilbronn, University of Heidelberg, Heidelberg, Germany.
- Journal
- J Urol. 2007 May;177(5):1771-5; discussion 1775-6.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
